Literature DB >> 16597845

Development of conventional and real-time nucleic acid sequence-based amplification assays for detection of Chlamydophila pneumoniae in respiratory specimens.

K Loens1, T Beck, H Goossens, D Ursi, M Overdijk, P Sillekens, M Ieven.   

Abstract

Isothermal nucleic acid sequence-based amplification (NASBA) was applied to the detection of Chlamydophila pneumoniae 16S rRNA by using the NucliSens basic kit (bioMérieux, Boxtel, The Netherlands). The assay was originally developed as a conventional NASBA assay with electrochemiluminescence detection and was subsequently adapted to a real-time NASBA format by using a molecular beacon. C. pneumoniae RNA prepared from a plasmid construct was used to assess the analytical sensitivity of the assay. The sensitivity of the NASBA assay was 10 molecules of in vitro wild-type C. pneumoniae RNA and 0.1 inclusion-forming unit (IFU) of C. pneumoniae. In spiked respiratory specimens, the sensitivity of the C. pneumoniae NASBA assay varied between 0.1 and 1 IFU/100 mul sample, depending on the type of specimen. Finally, conventional and real-time NASBA were applied to respiratory specimens previously tested by PCR. A 100% concordance between the test results was obtained.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16597845      PMCID: PMC1448673          DOI: 10.1128/JCM.44.4.1241-1244.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  Application of NucliSens Basic Kit for the detection of Mycoplasma pneumoniae in respiratory specimens.

Authors:  K Loens; M Ieven; D Ursi; H Foolen; P Sillekens; H Goossens
Journal:  J Microbiol Methods       Date:  2003-07       Impact factor: 2.363

2.  Detection of Mycoplasma pneumoniae by real-time nucleic acid sequence-based amplification.

Authors:  K Loens; M Ieven; D Ursi; T Beck; M Overdijk; P Sillekens; H Goossens
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

3.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

4.  Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection.

Authors:  N Mogulkoc; S Karakurt; B Isalska; U Bayindir; T Celikel; V Korten; N Colpan
Journal:  Am J Respir Crit Care Med       Date:  1999-07       Impact factor: 21.405

5.  Development and evaluation of nucleic acid sequence based amplification (NASBA) for diagnosis of enterovirus infections using the NucliSens Basic Kit.

Authors:  Julie D Fox; Song Han; Agneta Samuelson; Yadan Zhang; M Lynne Neale; Diana Westmoreland
Journal:  J Clin Virol       Date:  2002-02       Impact factor: 3.168

6.  Detection of Mycoplasma pneumoniae in spiked clinical samples by nucleic acid sequence-based amplification.

Authors:  K Loens; D Ursi; M Ieven; P van Aarle; P Sillekens; P Oudshoorn; H Goossens
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

7.  Sensitivity of detection of rhinoviruses in spiked clinical samples by nucleic acid sequence-based amplification in the presence of an internal control.

Authors:  Katherine Loens; Margareta Ieven; Stefaan Pattyn; Peter Sillekens; Herman Goossens
Journal:  J Microbiol Methods       Date:  2005-11-28       Impact factor: 2.363

Review 8.  A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR.

Authors:  J T Grayston; L A Campbell; C C Kuo; C H Mordhorst; P Saikku; D H Thom; S P Wang
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

9.  Single rapid real-time monitored isothermal RNA amplification assay for quantification of human immunodeficiency virus type 1 isolates from groups M, N, and O.

Authors:  M P de Baar; M W van Dooren; E de Rooij; M Bakker; B van Gemen; J Goudsmit; A de Ronde
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

10.  A newly discovered mycoplasma in the human urogenital tract.

Authors:  J G Tully; D Taylor-Robinson; R M Cole; D L Rose
Journal:  Lancet       Date:  1981-06-13       Impact factor: 79.321

View more
  7 in total

1.  Two quality control exercises involving nucleic acid amplification methods for detection of Mycoplasma pneumoniae and Chlamydophila pneumoniae and carried out 2 years apart (in 2002 and 2004).

Authors:  K Loens; T Beck; D Ursi; S Pattyn; H Goossens; M Ieven
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

2.  Evaluation of the combination of the NucliSENS easyMAG and the EasyQ applications for the detection of Mycoplasma pneumoniae and Chlamydia pneumoniae in respiratory tract specimens.

Authors:  E Béssède; H Renaudin; M Clerc; B de Barbeyrac; C Bébéar; S Pereyre
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-26       Impact factor: 3.267

3.  Direct sequencing of Legionella pneumophila from respiratory samples for sequence-based typing analysis.

Authors:  Mireia Coscollá; Fernando González-Candelas
Journal:  J Clin Microbiol       Date:  2009-07-15       Impact factor: 5.948

4.  Development of real-time multiplex nucleic acid sequence-based amplification for detection of Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Legionella spp. in respiratory specimens.

Authors:  K Loens; T Beck; D Ursi; M Overdijk; P Sillekens; H Goossens; M Ieven
Journal:  J Clin Microbiol       Date:  2007-11-21       Impact factor: 5.948

5.  Molecular beacons in diagnostics.

Authors:  Sanjay Tyagi; Fred Russell Kramer
Journal:  F1000 Med Rep       Date:  2012-05-02

Review 6.  Currently used nucleic acid amplification tests for the detection of viruses and atypicals in acute respiratory infections.

Authors:  Margareta Ieven
Journal:  J Clin Virol       Date:  2007-10-31       Impact factor: 3.168

7.  Enzymatic signal amplification of molecular beacons for sensitive DNA detection.

Authors:  Jianwei Jeffery Li; Yizhuo Chu; Benjamin Yi-Hung Lee; Xiaoliang Sunney Xie
Journal:  Nucleic Acids Res       Date:  2008-02-27       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.